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First they make you drink something that tastes like slime -
or British beer. Then you spend the majority of your day in
the smallest room in your house. Then they stick a tube into
you in a place normally discussed only in scatological humor.
And after it’s over, you spend the rest of the day producing
as much natural gas as Kazakhstan. I’ve had more fun at
faculty meetings.
I had my first colonoscopy last month, at age 59. I should
have had it nine years ago. In the US, as in Europe, about 4%
of the population will eventually be diagnosed with colon
cancer. In the United States alone, the disease accounts for
14% of all deaths from cancer, making it the second most
common cause of cancer death. The average age of onset is
64. Like many other diseases, the majority of cases of colon
cancer are sporadic, but a familial form, hereditary non-
polyposis colorectal cancer (HNPCC), is responsible for
approximately 2-7% of the 160,000 cases of colorectal
cancer that are diagnosed annually in the US.
Colon cancer is a solid cancerous growth that begins on the
inner surface of the colon or rectum. Virtually all colon
cancer develops from mushroom-like growths (called
adenomatous polyps) that form on the inside wall of the
colon. These polyps vary in size, but the larger a polyp is, the
greater the likelihood that it will become cancerous. For the
most part, it takes years for a polyp to become cancerous,
and in fact most polyps never turn malignant. About one in
four people develop adenomatous polyps by the age of 50,
even though most of them will never develop colon cancer.
Individuals diagnosed with inflammatory bowel disease (not
irritable bowel disease) are at increased risk for colon
cancer. In addition, other nongenetic factors include age
(isn’t it always?), above-average consumption of red meat, a
high-fat or low-fiber diet, obesity, a sedentary lifestyle, and
cigarette smoking. The Japanese, whose diet is relatively
high in fiber and low in fat, have significantly lower
incidence of colorectal cancer than do Westerners (although
their incidence of stomach cancer is higher), but when
Japanese men and women live in the West for extended
periods of time, their colon cancer rates rise, indicating that
diet plays a significant role.
HPNCC (also called Warthin-Lynch syndrome) is inherited
in an autosomal dominant fashion and people with this
disorder also have an increased risk of cancers of the
stomach, small intestine, liver, gallbladder ducts, upper
urinary tract, brain, skin, and prostate. Women with this
disorder also have a greatly increased risk of endometrial
and ovarian cancer. Despite the term nonpolyposis, people
with HNPCC occasionally do have colon polyps, which occur
at an earlier age than in the general population and are more
prone to become cancerous.
Thanks to the tools of genomics, the molecular genetics of
colorectal carcinoma are among the best understood of the
common human cancers. Typically, inactivation of the APC
(adenomatous polyposis coli) gene initiates colorectal
neoplasia leading to polyp formation. In patients with
familial adenomatous polyposis, germline inactivation of
APC appears to be followed by its somatic inactivation in
colorectal epithelium, typically leading to large numbers of
polyps. As these progress to malignancy, additional altera-
tions accumulate in proto-oncogenes, including ras, and in
tumor suppressor genes on chromosome 18q (DCC, Smad2,
or  Smad4) and 17p (p53). The alterations, each of which
appears to provide a selective growth advantage, are found
in various combinations in colon cancers. About 15% of colo-
rectal cancers are characterized by microsatellite instability
(MSI), also termed DNA replication errors or ubiquitous
somatic mutations. Inactivation of one of a group of genes
whose products participate in postreplicative repair of
nucleotide mismatches leads to insertions and deletions of
nucleotides in intrinsically unstable repeated sequences
(microsatellites) throughout the genome because of defec-
tive repair of the slippage mistakes made by DNA poly-
merases. MSI-positive tumors thus accumulate numerousframeshift mutations but also have a mutator phenotype that
increases both base substitution mutations and frameshift
mutations in expressed genes. In patients with HNPCC,
germline mutation of hMSH2 (human MutS homolog 2),
hMLH1 (human MutL homolog 1), hPMS1 or hPMS2 (human
postmeiotic segregation 1 and 2), or the  GTBP
(guanine/thymidine mismatch-binding protein)/hMSH6
gene, all of which code for DNA repair proteins, predispose
to tumorigenesis. In addition to germline and somatic
alterations in these genes in HNPCC, somatic inactivation of
mismatch repair genes has been identified as a cause of MSI
in sporadic tumors.
The tragedy of colorectal cancer is that it is one of the most
preventable of fatal diseases. Symptoms of colon cancer
include rectal bleeding, unexplained weight loss, constipa-
tion or diarrhea, abdominal pain, and a marked decrease in
the diameter of your stools. However, colon cancer often
fails to produce any symptoms until the cancer has grown
very large or metastasized, so the early identification and
subsequent removal of polyps through regular screening is
the best method of colon cancer prevention. Surgical
removal of polyps before they progress to malignancy or
metastasize leads to a very favorable outcome. All adults
over 50 years of age should be screened for colon cancer
since regular screening has been shown to reduce colon
cancer deaths. People who are at increased risk of develop-
ing colon cancer (for example, those with a familial history
of the disease) should begin screening at a younger age and
be screened more frequently. The presence of polyps that are
known to progress frequently to malignancy also means that
the affected individual should be screened more often than
someone with no such growths.
I indicated what the procedure is like at the start of this
column. It involves first taking large amounts of laxative to
clean out the colon the day before the examination. During
the colonoscopy itself, the physician uses a colonoscope (a
long, flexible instrument about half an inch in diameter) to
view the lining of the colon. The colonoscope is inserted
through the rectum and advanced to the large intestine.
During the colonoscopy, polyps can be identified and
removed for biopsy. In many cases, colonoscopy allows
accurate diagnosis and treatment without the need for a
major operation. Although the procedure sounds incredibly
unpleasant, it’s done under intravenous sedation (typically
with midazolam and fentanyl or Demerol), and the patient
usually has no memory of the procedure at all - I certainly
didn’t. So the worst part is actually taking the laxative,
although periods of flatulence for a day or so are a common
aftereffect because of the introduction of air into the colon
during the examination (don’t ask me how I know this).
Colonoscopy has a low (0.2%) risk of serious complications;
the most serious is a tear or hole in the lining of the colon
called a gastrointestinal perforation, which is life-threatening
and requires immediate major surgery for repair. However,
the rate of perforation is less than 1 in 2,000 colonoscopies.
Still, you want someone to do this procedure who does a lot
of them.
The relative merits of colonoscopy versus sigmoidoscopy
(which only examines the final two feet of the 4-5 foot long
colon) in colon cancer screening has been a source of on-
going debate. Recent articles in The New England Journal
of Medicine have suggested that colonoscopy is superior to
flexible sigmoidoscopy as a colon cancer screening method,
but to get regular screening of some sort is more important
than what screening tests are used, according to experts.
As I said, I should have had my first screening nine years
ago. I finally got one because I have a new primary care
physician, who specializes in preventive medicine, and who
makes my old army drill sergeant seem like a shrinking
violet. Why did I wait so long? It wasn’t because I was reluc-
tant to undergo an unpleasant experience (OK, maybe it was
a little), or because I was afraid of what might be found.
Quite the contrary: with no history of colorectal cancer on
either side of my family and an absence of most other risk
factors (I’ve never smoked, I exercise regularly), I figured
there was no rush. Now that I know more about the
prevalence of this disease and the very high percentage of
sporadic cases, I realize that I was stupid to delay being
screened. My colonoscopy detected several small polyps,
which were removed during the procedure and biopsied. I
was relieved to learn that they were not malignant, nor were
they the kind that turn malignant, which means that I don’t
have to undergo another colonoscopy for ten years. I
guarantee you that I will have that one on schedule.
So if you’re 50 or older, don’t wait as long as I did to have
your first colonoscopy. Do it now. I have to be honest with
you: you won’t enjoy the experience. As I said, I’ve had more
fun. But it’s a load off my mind. Or wherever.
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